ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,149,822 | -2.7% | 72,225 | 0.0% | 0.04% | -10.4% |
| Q3 2022 | $1,182,000 | +16.1% | 72,225 | 0.0% | 0.05% | +20.0% |
| Q2 2022 | $1,018,000 | -41.8% | 72,225 | 0.0% | 0.04% | -34.4% |
| Q1 2022 | $1,749,000 | +3.7% | 72,225 | 0.0% | 0.06% | +13.0% |
| Q4 2021 | $1,686,000 | -79.2% | 72,225 | -78.2% | 0.05% | -79.5% |
| Q2 2021 | $8,092,000 | -5.5% | 331,789 | 0.0% | 0.26% | -10.5% |
| Q1 2021 | $8,560,000 | -51.7% | 331,789 | 0.0% | 0.29% | -52.8% |
| Q4 2020 | $17,737,000 | +71.5% | 331,789 | +32.3% | 0.62% | +60.6% |
| Q3 2020 | $10,343,000 | -14.9% | 250,743 | 0.0% | 0.39% | -16.2% |
| Q2 2020 | $12,154,000 | +29.8% | 250,743 | +13.2% | 0.46% | +9.5% |
| Q1 2020 | $9,363,000 | +0.3% | 221,599 | +1.5% | 0.42% | +19.8% |
| Q4 2019 | $9,338,000 | +62.0% | 218,283 | +36.3% | 0.35% | +40.6% |
| Q3 2019 | $5,764,000 | +34.6% | 160,147 | 0.0% | 0.25% | +43.4% |
| Q2 2019 | $4,281,000 | +52.2% | 160,147 | +52.9% | 0.18% | +53.5% |
| Q1 2019 | $2,812,000 | +44.6% | 104,714 | +11.8% | 0.11% | +60.6% |
| Q3 2018 | $1,945,000 | +35.9% | 93,689 | 0.0% | 0.07% | +31.5% |
| Q2 2018 | $1,431,000 | -32.0% | 93,689 | 0.0% | 0.05% | -34.1% |
| Q1 2018 | $2,105,000 | -71.6% | 93,689 | -61.9% | 0.08% | -71.3% |
| Q4 2017 | $7,404,000 | +129.7% | 245,885 | +119.9% | 0.29% | +108.8% |
| Q4 2016 | $3,224,000 | -9.3% | 111,800 | 0.0% | 0.14% | 0.0% |
| Q3 2016 | $3,556,000 | -69.9% | 111,800 | -69.3% | 0.14% | -71.6% |
| Q2 2016 | $11,802,000 | -41.0% | 363,585 | -49.2% | 0.48% | -43.4% |
| Q1 2016 | $20,000,000 | -12.0% | 715,299 | +12.2% | 0.85% | +3.3% |
| Q4 2015 | $22,727,000 | +22.2% | 637,500 | +13.3% | 0.82% | +23.2% |
| Q3 2015 | $18,602,000 | +20.0% | 562,500 | +52.0% | 0.67% | +19.3% |
| Q2 2015 | $15,496,000 | – | 370,000 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |